MedPath

Comparison of Two Dosing Regimens of GW433908/Ritonavir Versus Lopinavir/Ritonavir for 48 Weeks in HIV Patients Who Have Taken Protease Inhibitors and Experienced Virological Failure

Phase 3
Conditions
HIV Infections
Registration Number
NCT00025727
Lead Sponsor
GlaxoSmithKline
Brief Summary

The purpose of this study is to test 2 different dosing regimens of GW433908/ritonavir (RTV) versus lopinavir (LPV)/RTV when each is given with 2 active reverse transcriptase inhibitors (RTIs), in patients who have taken anti-HIV drugs without success.

Detailed Description

Patients will receive 2 dosing regimens of GW433908/RTV or LPV/RTV, in combination with 2 active RTIs, after failing their first or second protease inhibitor-containing regimen. Patients are required to be on therapy at time of screening and must remain on this therapy until Day 1.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
330
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (32)

Bach and Godofsky

๐Ÿ‡บ๐Ÿ‡ธ

Bradenton, Florida, United States

Therafirst Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Fort Lauderdale, Florida, United States

Rush Med College / Dept of Infectious Diseases

๐Ÿ‡บ๐Ÿ‡ธ

Chicago, Illinois, United States

Boston Med Ctr / Evans - 556

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Med College of Georgia

๐Ÿ‡บ๐Ÿ‡ธ

Augusta, Georgia, United States

Community Health Care

๐Ÿ‡บ๐Ÿ‡ธ

Fort Lauderdale, Florida, United States

Orange Coast Med Group

๐Ÿ‡บ๐Ÿ‡ธ

Newport Beach, California, United States

Denver Inf Disease Consultants

๐Ÿ‡บ๐Ÿ‡ธ

Denver, Colorado, United States

Pacific Horizons Med Group

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco, California, United States

ID Care Inc

๐Ÿ‡บ๐Ÿ‡ธ

Somerville, New Jersey, United States

Bisher Akil

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

Ocean View Internal Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Long Beach, California, United States

Tower ID Med Associates

๐Ÿ‡บ๐Ÿ‡ธ

Los Angeles, California, United States

Gervais Frechette

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

Garden State Infectious Diseases / E I P Kennedy Health Sys

๐Ÿ‡บ๐Ÿ‡ธ

Voorhees, New Jersey, United States

Phoenix Body Positive

๐Ÿ‡บ๐Ÿ‡ธ

Phoenix, Arizona, United States

Florida ID Group

๐Ÿ‡บ๐Ÿ‡ธ

Orlando, Florida, United States

Fanno Creek Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Portland, Oregon, United States

South Jersey Infectious Diseases Inc

๐Ÿ‡บ๐Ÿ‡ธ

Somers Point, New Jersey, United States

Virginia Commonwealth Univ

๐Ÿ‡บ๐Ÿ‡ธ

Richmond, Virginia, United States

Joseph Gathe

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

Duke Univ Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Durham, North Carolina, United States

Abbott-Northwestern Hosp / Clinic 42

๐Ÿ‡บ๐Ÿ‡ธ

Minneapolis, Minnesota, United States

Methodist Healthcare

๐Ÿ‡บ๐Ÿ‡ธ

Memphis, Tennessee, United States

West Florida Clinical Research Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Pensacola, Florida, United States

Physicans Home Service

๐Ÿ‡บ๐Ÿ‡ธ

Washington, District of Columbia, United States

IDC Research Initiative

๐Ÿ‡บ๐Ÿ‡ธ

Altamonte Springs, Florida, United States

Southampton Healthcare Inc

๐Ÿ‡บ๐Ÿ‡ธ

St. Louis, Missouri, United States

North Broward Hosp District / HIV Clinical Research

๐Ÿ‡บ๐Ÿ‡ธ

Fort Lauderdale, Florida, United States

Discovery Alliance Inc

๐Ÿ‡บ๐Ÿ‡ธ

Pensacola, Florida, United States

Summa Health System

๐Ÿ‡บ๐Ÿ‡ธ

Akron, Ohio, United States

Roger Williams Med Ctr

๐Ÿ‡บ๐Ÿ‡ธ

Providence, Rhode Island, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath